Contract Development Services

Jun 19, 2018
By Pharmaceutical Technology Editors
WuXi STA supported the development of hepatitis drug through marketing authorization holder pilot program.
Jun 19, 2018
By Pharmaceutical Technology Editors
The extension provides four additional process development laboratories at its Nottingham site to improve output and efficiency in drug development and clinical trial manufacturing operations.
Jun 07, 2018
By Pharmaceutical Technology Editors
Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.
Jun 06, 2018
By Pharmaceutical Technology Editors
Under the contract, AMRI will focus on the development and manufacture of APIs and drug product for Phase I clinical studies.
Jun 02, 2018
Pharmaceutical Technology
From separation systems to reactor technology, new tools are increasing the feasibility of continuous API production.
Jun 01, 2018
By Pharmaceutical Technology Editors
Cambrex invests $5 million in new laboratory expansion at its Karlskoga, Sweden facility.
Jun 01, 2018
By Pharmaceutical Technology Editors
Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.
Jun 01, 2018
By Pharmaceutical Technology Editors
Madison Dearborn Partners will acquire a majority ownership position in CDMO Alcami.
May 16, 2018
By Pharmaceutical Technology Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
Apr 24, 2018
By Pharmaceutical Technology Editors
Porton will use biocatalyst technologies from Codexis to accelerate API development for clients.
native1_300x100
lorem ipsum